Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 4
1983 2
1984 4
1985 5
1986 8
1987 2
1988 6
1989 3
1990 3
1991 3
1992 2
1993 4
1994 6
1995 7
1996 5
1997 5
1998 4
1999 6
2000 8
2001 7
2002 11
2003 8
2004 10
2005 10
2006 14
2007 9
2008 10
2009 13
2010 15
2011 19
2012 25
2013 39
2014 23
2015 26
2016 30
2017 16
2018 23
2019 25
2020 19
2021 30
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

432 results
Results by year
Filters applied: . Clear all
Page 1
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.
Tomita I, Kume S, Sugahara S, Osawa N, Yamahara K, Yasuda-Yamahara M, Takeda N, Chin-Kanasaki M, Kaneko T, Mayoux E, Mark M, Yanagita M, Ogita H, Araki SI, Maegawa H. Tomita I, et al. Among authors: maegawa h. Cell Metab. 2020 Sep 1;32(3):404-419.e6. doi: 10.1016/j.cmet.2020.06.020. Epub 2020 Jul 28. Cell Metab. 2020. PMID: 32726607 Free article.
Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T. Tagawa A, et al. Among authors: maegawa h. Diabetes. 2016 Mar;65(3):755-67. doi: 10.2337/db15-0473. Epub 2015 Sep 17. Diabetes. 2016. PMID: 26384385
A role for bone marrow-derived cells in diabetic nephropathy.
Nobuta H, Katagi M, Kume S, Terashima T, Araki SI, Maegawa H, Kojima H, Nakagawa T. Nobuta H, et al. Among authors: maegawa h. FASEB J. 2019 Mar;33(3):4067-4076. doi: 10.1096/fj.201801825R. Epub 2018 Nov 29. FASEB J. 2019. PMID: 30496699
Roles of mTOR in Diabetic Kidney Disease.
Yasuda-Yamahara M, Kume S, Maegawa H. Yasuda-Yamahara M, et al. Among authors: maegawa h. Antioxidants (Basel). 2021 Feb 22;10(2):321. doi: 10.3390/antiox10020321. Antioxidants (Basel). 2021. PMID: 33671526 Free PMC article.
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).
Yagi N, Komiya I, Arai K, Oishi M, Fukumoto Y, Shirabe S, Yokoyama H, Yamazaki K, Sugimoto H, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group),. Yagi N, et al. Among authors: maegawa h. J Diabetes Investig. 2022 Jan;13(1):65-73. doi: 10.1111/jdi.13621. Epub 2021 Jul 30. J Diabetes Investig. 2022. PMID: 34191401 Free PMC article.
Autophagy as a therapeutic target in diabetic nephropathy.
Tanaka Y, Kume S, Kitada M, Kanasaki K, Uzu T, Maegawa H, Koya D. Tanaka Y, et al. Among authors: maegawa h. Exp Diabetes Res. 2012;2012:628978. doi: 10.1155/2012/628978. Epub 2011 Oct 19. Exp Diabetes Res. 2012. PMID: 22028701 Free PMC article. Review.
[Glucose].
Maegawa H. Maegawa H. Nihon Rinsho. 1999 Aug;57 Suppl:592-4. Nihon Rinsho. 1999. PMID: 10503510 Review. Japanese. No abstract available.
Autophagy: emerging therapeutic target for diabetic nephropathy.
Kume S, Yamahara K, Yasuda M, Maegawa H, Koya D. Kume S, et al. Among authors: maegawa h. Semin Nephrol. 2014 Jan;34(1):9-16. doi: 10.1016/j.semnephrol.2013.11.003. Epub 2013 Nov 21. Semin Nephrol. 2014. PMID: 24485025 Review.
The role of autophagy in the pathogenesis of diabetic nephropathy.
Yamahara K, Yasuda M, Kume S, Koya D, Maegawa H, Uzu T. Yamahara K, et al. Among authors: maegawa h. J Diabetes Res. 2013;2013:193757. doi: 10.1155/2013/193757. Epub 2013 Dec 17. J Diabetes Res. 2013. PMID: 24455746 Free PMC article. Review.
432 results